59 GPNMB:CD44 Signaling Drives Tumor Progression in Translocation Renal Cell Carcinoma
Abstract Background MiT/TFE-rearranged, translocation renal cell carcinoma (tRCC) is characterized by gene fusions involving TFE3 or TFEB, and is a rare, aggressive non-ccRCC, often occurring in children and with few biomarkers or targeted therapy options. TFE3 is the most commonly translocated gene with ASPSCR1, PRCC...
K. Asrani, Juhyung Woo, Thiago Vidotto et al.
· The Oncologist · 0 citations